Učitavanje...
Ex vivo analysis of topotecan: advancing the application of laboratory-based clinical therapeutics
Topotecan is currently approved for relapsed small-cell lung cancer and ovarian cancer. Topotecan's efficacy in the second-line setting and novel mechanism of action suggest broad antitumour activity. We utilised a clinically validated, cell-death, ex vivo assay in human tumour explants to exam...
Spremljeno u:
| Glavni autori: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group
2003
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2394409/ https://ncbi.nlm.nih.gov/pubmed/14583785 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601336 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|